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Effectiveness and cost-effectiveness of a Yoga-based Cardiac Rehabilitation 
(Yoga-CaRe) program following acute myocardial infarction: 
Study rationale and design of a multi-centre randomized controlled trial 
Background 
Coronary artery disease (CAD) is the leading cause of death and disability in India. 
[1,2]  The psychosocial and economic aspects of CAD are particularly important, as 
CAD typically manifests at younger ages (<55 years) in previously healthy adults. 
These adults experience considerable difficulty in accepting their illness, resulting in 
reduced enthusiasm to engage with the family and return to economically productive 
activity. [3] Hence, there is a compelling need for effective secondary prevention 
interventions, aimed at improving both the duration and the quality of life of those 
affected.   
Cardiac rehabilitation (CR) is the process of restoring desirable levels of physical, 
social, and psychological functioning after the onset of CAD or after interventions for 
CAD. It is typically achieved through a program of exercise and information sessions. 
CR programs for patients with CAD have been shown to reduce mortality and 
hospital admissions, improve quality of life, and reduce the costs associated with 
care. [4–6] However, CR programs are unavailable to most patients in India ) due to 
high costs and skills required for multidisciplinary CR teams. [7] The WHO Global 
action plan for the prevention of non-communicable diseases (NCDs) has advocated 
for harnessing the potential of traditional and complementary therapies because of 
their potentially lower costs and greater cultural acceptability. [8] Although alternate 
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models of CR based on complementary and alternative therapies have been 
proposed, their clinical effectiveness and safety is yet to be established. [9,10] Low-
cost and sustainable CR programs based on local traditional practices could address 
the unmet need of CR globally. 
Yoga is an ancient Indian system of mind-body discipline, encompassing an array of 
philosophical precepts, mental attitudes and physical practices. [11]  Although it is 
practiced in many forms, the most common ones incorporate elements of physical 
poses, breathing practices and meditation, and moderation in lifestyle including diet, 
stress and sleep and abstinence from smoking and alcohol. As such, it covers the 
core elements of a CR program: improved physical conditioning, stress reduction 
and lifestyle moderation. The structure of a yoga training program is also similar to 
CR (a series of exercise-cum-education sessions, but requires considerably fewer 
resources (i.e. a basic instructor). Yoga, therefore, could provide a useful framework 
on which to develop an economical CR program for India.  
Strong rationale exists for the use of yoga in the prevention of cardiovascular 
diseases. Studies suggest yoga down-regulates effects of stress (primarily on blood 
pressure) mediated by hypothalamic-pituitary-adrenal axis (e.g. cortisol), specifically 
the renin-angiotensin system, and the sympathetic nervous system (e.g. 
improvement in baroreceptor sensitivity). [12–14] Variable improvements in 
functional capacity (e.g. ventricular structure/function), inflammatory markers, carotid 
intima-media thickness and other conventional cardiovascular risk factors (e.g. 
insulin, lipids) are also reported. [15] Also, yoga has been shown to improve health 
related quality of life in chronic diseases. [16–19] However, these studies have been 
limited by small sample sizes, lack of control groups and unmasked assessment of 
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outcomes. [20–22]. We therefore hypothesized that yoga could be an useful cardiac 
rehabilitation tool. We propose to evaluate this through a randomized control trial.  
Methodology 
Study design and recruitment strategy 
This is a multi-center, single-blind, two-arm parallel group, randomized controlled 
trial (RCT) conducted across 24 cardiac centers in India. The study sites include a 
mix of public funded, teaching hospitals and private hospitals to allow recruitment of 
patients from a wide range of socio-economic backgrounds. As is typical of India, 
most (19/22 clinical sites) did not have existing formal CR programs. Patients are 
assessed for eligibility after signing a written informed consent form. 
Inclusion and exclusion criteria 
Inclusion criteria Patients are considered to be eligible for the study if they meet the 
following criteria: 
1. Aged 18-80 years 
2. Experienced first or subsequent AMI and survived to hospital discharge within 14 
days of AMI. AMI  confirmed by the World Health Organization definition 
(presence of symptoms of ischemia and changes in electrocardiogram) or the 
Third Universal Definition of Myocardial Infarction (elevation of a cardiac 
biomarker along with presence of either symptoms of myocardial infarction or 
changes in electrocardiogram). [23,24] 
3. Willing and able to attend the complete hospital-based CR program on their own 
Exclusion criteria Patients are ineligible if they meet any of the following criteria at 
screening: 
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1. Site investigators consider that the patient will be unable to complete the study 
and/or attend for follow-up 
2. Regularly practice yoga i.e., more than 3 hours a week  
3. Currently participating in any other clinical trials 
4. Have any other diseases which limit their life to less than a year (e.g. severe 
valvular disease, recurrent ventricular arrhythmias, NYHA Class 4 heart failure, 
severe aortic incompetence, severe atrial fibrillation, cancers, and end-stage 
renal or liver disease  
Randomization 
Eligible and consenting patients are randomized (block randomization, stratified by 
age-band (< or ≥ 60 years) and gender) in a 1:1 ratio by a computer program 
centrally (Research coordinating center (RCC), New Delhi) using an interactive web 
response system (IWRS) and after collecting key identifying data.  
We chose individual randomization (within centers) over cluster randomization (with 
centers as clusters) because we considered potential bias from differences in clinical 
practice between centers to be a more serious threat to study validity than 
contamination, particularly because Yoga-CaRe as a CR program would not be 
available externally, even if yoga classes could be.  
Interventions:  
Yoga-CaRe program 
The Yoga-CaRe program was developed using a structured process. This included a 
literature review and qualitative and quantitative interviews with yoga experts, CR 
experts and patients with myocardial infarction to systematically identify and shortlist 
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appropriate yoga exercises and postures, breathing exercises, meditation and 
relaxation practices, and lifestyle changes, which were incorporated into a 
conventional CR framework. . The details of the CR program are under review for 
publication elsewhere. Briefly, it involves 13 hospital-based sessions spread over 3 
months (Table 1). Patients are also encouraged to practice daily at home following 
the instructions provided in a DVD and booklet. The first two sessions are delivered 
individually, with the remaining in groups. The exercise-cum-education sessions 
involve a combination of exercises related to general physical conditioning, stress 
and relaxation (health rejuvenating exercises- around 10 minutes, yoga poses- 25 
minutes, breathing exercises-15 minutes, meditation and relaxation practices- 15 
minutes; and moderated discussion- 10 minutes), and some exercises believed to be 
of particular cardio-protective benefit in yogic texts. The lifestyle and other 
educational components are informed by yogic ideas but moderated by established 
scientific evidence. Spouses or care-givers are also encouraged to attend the 
sessions where possible and assist the participant at home.  
Table 1 Model of Yoga-CaRe in relation to the standard four-phase model of CR 
Phase Yoga-CaRe 
1 Inpatient/outpatient care  Week 1-2: Education session (Session 1) (one hour) 
2 Formal outpatient CR 
program I 
Week 3: Exercise session (Session 2) (30 minutes) 
3 Formal outpatient CR 
program II 
Weeks 5-7: Exercise-education sessions, twice per week 
(Sessions 3-8)*  
Weeks 8-12: Exercise-education sessions, once per week 
(Sessions 9-13)*  
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(Each Session - 75 minutes including moderated discussion) 
4 Long-term maintenance 
of lifestyle changes & self-
practice of yoga at home 
Weeks 13+: Maintenance of lifestyle changes & self-practice of 
yoga at home using the booklet & DVD provided  
* In addition to the outpatient training visits, self-supervised sessions (1 hour) with 
DVD and book at home, 5-7 times per week 
 
The practices are delivered by a trained Yoga-CaRe instructor (one instructor at 
each of the clinical site) with prior experience of yoga (at least one year training). 
Yoga-CaRe instructors received training in the delivery of the Yoga-CaRe program 
by our team of cardiologists, cardiac rehabilitation experts and yoga experts during 
an initial induction program followed by refresher training programs every 12 months. 
This also includes didactic lectures on anatomy and physiology of the cardiovascular 
system, communicating with patients, barriers and facilitators to cardiac rehabilitation 
program and importantly identifying warning signs or distress symptoms. In addition, 
manual for instructors was provided to the instructors in their local language. We are 
video-recording of 10 sessions in each of the participating centers and around 80 
sessions are video-recorded; these are supplemented by direct observations of the 
sessions by the study team. Data on adherence to home-practices are collected by 
questionnaires completed during each follow-up session.  
 
Control:  
Enhanced standard care  
Patients in the control group receive enhanced standard care in the form of 
educational advice with a leaflet, once before discharge from the hospital and 
7 
 
subsequently at weeks 5 and 12 (sessions 2 and 3) along with standard medical 
care  as elsewhere in India but does not include rehabilitation [25]. The sessions are 
delivered in groups or individually by a different member of the team (not yoga 
instructor) to avoid contamination.  
Outcome measures and data collection 
Primary outcomes 
The co-primary outcomes are cardiac mortality and morbidity over the follow-
up period, and quality of life at 12 weeks.  
The cardiac mortality and morbidity outcome is the time to first cardiovascular event 
which is a composite of all-cause mortality, nonfatal myocardial infarction, and 
nonfatal stroke, hospitalizations for emergency revascularization, unstable angina 
and heart failure. The documents related to the events such as death certificates, 
admission and discharge summary etc are prospectively collected and the outcomes 
are adjudicated by an Endpoint Adjudication Committee blinded to treatment 
allocation (Supplementary file).  
The quality of life is assessed using the European Quality of Life questionnaire 
(EuroQol EQ-5D-5L) at 12 weeks. EQ-5D was chosen because it has been validated 
against longer and disease specific questionnaires in acute coronary syndrome 
patients undergoing cardiac rehabilitation and found to be valid, reliable and 
responsive. [26] In addition, it is brief (important for telephonic completion) and local 
translation versions available in all major Indian languages. Those not appearing for 
the clinic visit have their assessment completed telephonically. The timing of this 
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assessment is chosen so as to capture both the speed and completeness of 
functional recovery.   
Secondary outcomes 
Data on any revascularization procedures [coronary artery bypass surgery (CABG) 
and percutaneous coronary interventions (PCI)] during the trial period are collected 
using the same process as the cardiovascular events.  
Data on return to pre-infarct daily activities is assessed by Reintegration to Normal 
Living Index (RNLI). [27] The questionnaire contains 11 statements and the 
responses are evaluated in a visual analogue scale. Those not appearing for the 
clinic visit have their assessment completed telephonically.  
Tobacco cessation is based on self-reports. In a random subset of about 5% of the 
trial population, salivary samples are collected to validate self-reports.  
Adherence to prescribed medication is assessed by Morisky Medication Adherence 
Scale (MMAS). MMAS has a high sensitivity and has been used in Indian settings in 
the past.. [28]  
Data on cognitive function is being collected using the Montreal Cognitive 
Assessment (MoCA), and anxiety and depression using Hospital Anxiety and 
Depression Scale (HADS), in a subset of participants (n=400). MoCA and HADS are 
validated and widely accepted tools for assessing cognitive assessment and anxiety 
respectively. [29,30]  
Every participant will be followed for a minimum of six months till end of the trial. The 
end of study differs for each participant depending on the time they were enrolled 
into the study. The site coordinators upload the data collected from participants 
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through electronic case report forms to the central database located in the Research 
Coordinating Centre (RCC). The database has a limited access password protected 
system and constructed with built-in range checks to avoid errors in data. Also, the 
data are cross-checked against the source documents during regular on-site 
monitoring visits and regular central statistical monitoring to detect outliers and data 
discrepancies. At the clinical site, collected data is protected in fire-proof and locked 
safes. All the participant data will be de-identified in the final dataset and will be 
made available for bonafide researchers upon request to the investigators. 
 Table 2: Schema of data collection in Yoga-CaRe trial 
Outcome measure Time of data collection  
Primary outcome measures 
1. Cardiovascular events 
 
2. Quality of life 
 
1. Every three months till the end of the 
study 
2. Baseline, three months, nine months 
and end of study. 
Secondary outcome 
measures 
1. Need for 
revascularization 
procedures 
2. Return to pre-infarct daily 
activities 
3. Tobacco cessation  
 
 
 
1. Every three months till the end of the 
study 
 
2. Baseline, three months, nine months 
and end of study. 
3. Baseline, three months, nine months 
and end of study. 
10 
 
4. compliance to 
medications 
5. Costs of care 
 
6. Cognitive function, 
anxiety and depression 
4.  Baseline, three months, nine months 
and end of study. 
5. Every three months till the end of the 
study 
6. Baseline, three months, nine months 
and end of study 
 
Sample size estimation 
The required sample size was estimated using incidence data from a multinational 
registry that includes India (cumulative annual incidence rate of ~20-25% for a 
composite outcome of all-cause mortality, nonfatal MI and stroke, following AMI) [31] 
and effectiveness data from systematic reviews of CR trials (a 20-25%  reduction in 
adverse vascular outcomes). The total sample required was initially estimated as 
3,102, assuming 20% annual incidence in the control arm and a 20% effect size at a 
median follow-up of 12 months, a 10% loss to follow-up, at 80% power and 5% 
significance level. Estimation was based on time-to-first-event data (censoring the 
patient subsequently). Midway through the study, the sample size was re-estimated 
to account for a lower observed incidence of outcomes, which is consistent with a 
rapid improvement in cardiac care in India over the last decade. We therefore 
proposed to recruit 5000 patients; however, the Data Monitoring and Ethics 
committee recommended stopping recruitment at 4000 and extending the study 
follow-up after reporting the results until this point (including the minimum 6 months 
follow-up).  
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A considerably smaller sample is required to detect differences in quality of life; a 
total sample of 818 (409 in each group) would be adequate to detect a 5% difference 
in the mean EQ-5D scores, with 95% confidence. 
Analysis of outcomes  
The observed difference in the hazard of the first adverse vascular event (censoring 
subsequent events) between the treatment and the control arm will be assessed by 
fitting a Cox proportional hazards model. Cardiovascular events will be estimated by 
the Kaplan–Meier method and comparisons made by the Log rank test. The primary 
analysis for the quality of life will be assessed by estimating the difference between 
the treatment arms in the change score from baseline to 12 weeks in health 
thermometer by fitting conventional regression models. Also, EQ-5D-5L index as a 
whole and its five dimensions will be analyzed as scaled outcomes and differences 
between treatment arms will be examined by fitting regression models.  
All primary analyses will be on an intention to treat principle and will be unadjusted, 
and subsequently adjusted for covariates with baseline imbalances including centre. 
We will also report the per-protocol or on treatment analyses. For missing data, 
sensitivity analyses will be conducted for primary end points, including a complete 
case analysis and multiple imputations to evaluate the potential effect of 
missingness. 
Economic analyses  
We will calculate health expenditures and within-trial cost-effectiveness of the 
intervention compared to enhanced standard care using a health care system and 
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patient perspective as our base-case analysis, and a societal perspective in 
sensitivity analyses.  
Health expenditures will include direct medical costs and implementation/delivery 
costs of the intervention (i.e. costs attributable to research activities will be excluded) 
from our clinic and study expenditures. We will estimate the incremental costs of 
intervention (outpatient visits, medications, in-patient hospitalizations, and indirect 
medical costs) compared to enhanced standard care group. Given that public and 
private clinics are participating in our trial, we will also report expenditures for 
interventions relative to enhanced standard care by type of clinic and cumulatively. 
The primary outcome for cost-effectiveness will be major adverse cardiovascular 
events (MACE) averted and quality adjusted life years (QALYs) gained. Both MACE 
and QALY data are being collected over the trial duration. QALYs can be compared 
across interventions and countries (using a ceiling ratio [set cost per QALY value as 
a reference point]). Uncertainty around incremental costs and incremental outcomes 
(MACE averted and QALYs gained) will be estimated using non-parametric 
bootstrap methods.  
A probabilistic decision analytic health state-transition model (Markov model) will be 
constructed to extrapolate the trial effects over patients’ lifetime horizon. A 
hypothetical cohort of acute myocardial infarction patients with a given set of 
characteristics (e.g. age, comorbidities) will be followed until death over successive 
time cycles of set length (1 year). Where available, appropriate prognostic models 
will be used to predict the time-dependent risk of major adverse cardiovascular 
events. The incurred costs and health outcomes over the model time horizon will be 
summed and averaged for intervention and enhanced standard care groups and the 
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long-term incremental cost-effectiveness of intervention will be calculated. An annual 
discount rate of 3% will be applied to both costs and outcomes, which will be varied 
in sensitivity analyses. A range of scenario analyses will be conducted to investigate 
the influence of alternative assumptions on the base case results. 
 
Ethical considerations and risks 
The Institutional ethics committee (IEC) of the Centre for Chronic Disease Control 
and London School of Hygiene and Tropical Medicine and the ethics committee of 
the individual participating/clinical sites approved the study protocol. Although this is 
a behavioral intervention and yoga is inherently safe, there is a small risk of adverse 
event from inappropriate practice or exertion, particularly among those in a poor 
health state after their AMI. Patients are carefully selected with the help of site 
investigators who are physicians and Yoga-CaRe instructors are trained to adapt the 
program to the ability of the patient and anticipate the symptoms of AMI. Yoga 
sessions are held in the hospital premises and clinical investigators made aware of 
them. Any serious adverse events at the sites are notified to respective ethics 
committees and periodically to the Data Monitoring and Ethics Committee (DMEC), 
the Trial Operations Committee and the Trial Steering Committee. All team members 
involved in the study including the Yoga–CaRe instructors are trained in Good 
Clinical Practice guidelines.   
Discussion 
CR programs are an integral part of cardiovascular management globally. [32,33] 
They effectively reduce mortality (up to half) and morbidity, improve quality of life, 
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lower medical and social costs, and increase economic productivity, comparing 
favorably to effective pharmacological treatments for secondary prevention of AMI 
(e.g. statins and beta blockers) with minimal side effects. Yet, their uptake remains 
low. In low and middle income countries (LMICs) such as India, the cost and skills 
required for large multidisciplinary teams used to deliver established CR programs is 
prohibitive, making them un-scalable. Even in HICs where CR programs are 
universally available, uptake is often low, particularly among disadvantaged groups 
such as women, the elderly and minority ethnic groups, who find the gymnasium 
style exercise programs unappealing due to unfamiliarity and cultural and attitudinal 
reasons. Hence there is an urgent need to develop other forms of CR programs 
which are affordable and culturally acceptable (in LMICs) and offer a choice (in 
HICs). [7,34]  Yoga-CaRe will address this unmet need if it is found to improve 
outcomes and is cost-effective, and may also instigate development of CR programs 
based on other cultural practices, such as the Chinese Tai Chi.  
Strengths and limitations 
Previous trials of CR in post MI patients have been relatively small randomizing up to 
a few hundred participants with exception of the WHO (1983) and West (2012) that 
randomized 3184 participants and 1813 participants respectively.[6] Also, most data 
are from the developed countries. Our trial will be considerably larger and will 
contribute to more than 20% of participants in meta-analyses of randomized trials of 
CR. Also, it is independently powered for policy relevant outcomes of clinical 
effectiveness. It is embedded within the typical healthcare system (mix of public and 
private) making findings generalizable, and has inbuilt economic data collection to 
undertake robust economic analyses to guide actions by policy makers and private 
healthcare providers. The intervention was designed to be extremely low cost and 
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scalable, ensuring immediate impact on policy and clinical practice. Conversely, the 
pragmatic design of the intervention (only a few supervised sessions) also precludes 
estimation of true efficacy of yoga for CR, increasing the likelihood of a false 
negative result. We lacked the resources to explore the role of specific mechanistic 
pathways that have been proposed for cardiovascular health effects of yoga. 
However, we have recently completed a separate parallel study on that question in 
the UK, which will be reporting its results soon.   
Trial status  
The trial commenced in August 2014 and will be completed by September 2018. A 
total of 4016 AMI patients have been recruited from 22 centers across India. The 
study results will be promulgated to the participating patients, physicians, yoga-
instructors, policy makers and general population through policy briefs and research 
papers after March 2019.   
Funding 
The study is funded through a collaborative research grant from the Indian Council 
for Medical Research and Medical Research Council, UK. (ICMR -58/1/9/MRC-
ICMR/2009/NCD-II and MRC- MR/J000175/1). The sponsors have no role in study 
design, data collection, management, analysis and interpretation of the data and 
dissemination of the results. 
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